The influence of constraints (i.e., barriers or limitations) on creativity has drawn attention from various fields but has largely yielded conflicting findings. Some studies suggest constraints may have a positive impact on creativity while others find a negative impact. In an effort to clarify this debate and provide direction for future efforts, this meta-analysis examined the relationship between constraints and creativity.Using a sample of 111 published and unpublished studies, a series of random-effects meta-regression models and subgroup analyses were conducted and identified a significant positive relationship between constraints and creativity. Moderator analyses confirmed the relationship differed substantially depending on the constraint type, study design, funding status, and creativity operationalization and measurement.These findings suggest that constraints may not be detrimental to creativity, despite prior assumptions. Findings further suggest that constraint type may be less influential than typically assumed. Instead, methodological artifacts provide a better explanation for the varying existing findings in how constraints benefit or hinder creativity. Theoretical and practical implications are discussed.

The pharmaceutical industry produces a large proportion of health system greenhouse gas (GHG) emissions, contributing to climate change. This urgently needs to be addressed. We aimed to examine pharmaceutical company climate change targets, GHG emissions, and strategies to reduce them. We performed content analysis of the 20 largest pharmaceutical companies’ publicly available 2020/2021 reports, focusing on extracting information on their reported climate change targets, GHG emissions (and whether companies had demonstrated any reduction in emissions over their reporting period), and strategies being implemented to reduce company emissions and meet their targets. Nineteen companies have committed to reducing GHG emissions, ten to carbon neutrality and eight to net zero emissions between 2025 and 2050. Companies showed largely favorable reductions in scope 1 (in-house) and scope 2 (purchased energy), with variable results in scope 3 (supply chain) emissions. Strategies to reduce emissions included optimizing manufacturing and distribution, and responsible sourcing of energy, water, and raw materials. Pharmaceutical companies are setting climate change targets and reporting reduced emissions via a range of strategies. This varies, with scope to track actions and accountability to targets, improve consistency of reporting, especially of scope 3 emissions, and collaborate on novel solutions. There is need for further mixed methods research on progress with achieving reported climate change targets, as well as implementation of strategies to reduce emissions within the pharmaceutical industry.

BACKGROUND• Professional medical writing support is associated with more complete reporting of randomized controlled trials (RCTs) and a higher quality of written English than articles without this support.

Word count: 270/275 (incl. title and headings; excl. authors, affiliations and references; tables permitted and count for 100 words)

The pervasiveness of unethical actions paired with the rising demand for creativity in organizations has contributed to an increased interest in how ethicality and creativity relate. However, there are mixed findings on whether these two fundamental pillars of the workplace relate positively, negatively, or not at all. To provide an empirical consensus to this debate, we study the directional effects of ethicality on creativity by employing meta-analytic techniques. Specifically, a series of meta-regressions, moderated meta-regressions, and individual subgroup analyses of moderators investigated the nuances of the ethicality-creativity relationship. Using a random-effects model, a quantitative review of 278 effects across 23 articles revealed that ethicality positively related to creativity. We further probed how each domain of ethicality (i.e., ethical decisionmaking, ethical leadership, ethical culture, ethical thought) related to creativity; the effect of ethicality on creativity remained positive, but was no longer significant. Additionally, to expand our understanding of this relationship, we offer theoretical and empirical accounts of five factors that moderate the positive association between ethicality and creativity: ethicality and creativity domains and measurement, sample culture, study characteristics, and sample characteristics. Theoretical and practical insights regarding these relationships are discussed. Keywords Creativity • Ethicality • Constraints • Meta-analysisSome of the [FCC regulations] actually ends up helping comedy. I think some restraints force you to be creative. -Elizabeth Meriwether, Creator of New Girl (Variety, 2021)